ClassID:

109137

C12N2310/122 - page 2 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid catalytic nucleic acids, e.g. ribozymes Hairpin

Recent Application in this class:
#301
20170029822
2017-02-02

Treatment using truncated Trk B and Trk C antagonists

#302
20170009231
2017-01-12

Methods used to treat cancer

#303
20160361391
2016-12-15

REDUCTION OF TRAF1 LEVELS COMBINED WITH NUTRIENT STRESS FOR TREATING LYMPHOCYTE-RELATED CANCERS

#304
20160312229
2016-10-27

Modulators of intracellular chloride concentration for treating down syndrome

#305
20160279256
2016-09-29

Multi-arm biodegradable polymers for nucleic acid delivery

#306
20160271229
2016-09-22

Methods for treating hepatitis C virus infectious disease

#307
20160263200
2016-09-15

Compositions and methods for promoting the mineralization of biological tissue

#308
20160263184
2016-09-15

METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1

#309
20160256524
2016-09-08

Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury

#310
20160251654
2016-09-01

Short hairpin RNA compositions, methods of making and applications thereof

#311
20160244764
2016-08-25

Methods for predicting the progression and treating a chronic kidney disease in a patient

#312
20160222131
2016-08-04

ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS

#313
20160040168
2016-02-11

Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient

#314
20160024494
2016-01-28

COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS

#315
20160018414
2016-01-21

SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers

#316
20160009804
2016-01-14

Therapeutic and diagnostic methods relating to cancer stem cells

#317
20160002626
2016-01-07

TOX INHIBITION FOR THE TREATMENT OF CANCER

#318
20150376586
2015-12-31

RNA Modification to Engineer Cas9 Activity

#319
20150299711
2015-10-22

Composition for treating cancer associated with HPV infection

#320
20150204874
2015-07-23

Predicting and treating diabetic complications

#321
20150080315
2015-03-19

Spalt-like transcription factor 4 (SALL4) and uses thereof

#322
20150056207
2015-02-26

COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS

#323
20150044234
2015-02-12

Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena

#324
20110287034
2011-11-24

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

#325
20110160289
2011-06-30

COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS

#326
20110117094
2011-05-19

Reactivation of axon growth and recovery in chronic spinal cord injury

#327
20100173412
2010-07-08

Eukaryotic layered vector initiation systems

#328
20090275100
2009-11-05

Compositions and methods for temperature-dependent nucleic acid synthesis

#329
20090226443
2009-09-10

COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS

#330
20090221807
2009-09-03

2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid

#331
20090170197
2009-07-02

Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)

#332
20080227160
2008-09-18

Circular DNA vectors for synthesis of RNA and DNA

#333
20080171388
2008-07-17

COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS

#334
20070280963
2007-12-06

Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors

#335
20070105108
2007-05-10

Polynucleotides capable of target-depedent circularization and topological linkage

#336
20070042029
2007-02-22

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

#337
20060270621
2006-11-30

Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs

#338
20060239990
2006-10-26

Protein Arginine N-Methyltransferase 2 (PRMT-2)

#339
20060223990
2006-10-05

Synthesis, deprotection, analysis & purification of RNA & ribozymes

#340
20060178326
2006-08-10

Ribozyme therapy for the treatment of proliferative skin and eye diseases

#341
20060142557
2006-06-29

2'-deoxy-2'alkylnucleotide containing nucleic acid

#342
20060105977
2006-05-18

Desmoglein 4 is a novel gene involved in hair growth

#343
20060074041
2006-04-06

Antisense and antigene therapeutics with improved binding properties and methods for their use

#344
20050260163
2005-11-24

Triplex hairpin ribozyme

#345
20050227937
2005-10-13

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

#346
20050176038
2005-08-11

Polymearase III-based expression of therapeutic RNAs

#347
20050096282
2005-05-05

Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases

#348
20050089922
2005-04-28

Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis

#349
20050042620
2005-02-24

RNA catalyst for cleaving specific RNA sequences

#350
14788045
2016-11-01

Conversion of non-neuronal cells into neurons